FirstWord belongs to a business group that forms one of the world’s largest healthcare knowledge networks. By tapping into its rich resources, FirstWord Dossier reports provide insight, analysis and the latest thinking on important trends and the most challenging issues affecting the pharmaceutical industry today. Highly-focused, relevant, up-to-date and actionable intelligence reports that deliver information vital for competitive advantage.

Page

New Commercial Models: Benchmarking Pharma Companies [2018]

By FirstWord Dossier | Healthcare | May 2018 | Page 0

How well has your business transitioned from a volume-driven to a value-driven model Pharma has made the shift from volume to value, but just how successful are these new commercial....

USD 2495 View Report

Paying for Digital Health: Payer Insights

By FirstWord Dossier | Healthcare | May 2018 | Page 0

Payers love digital technologies that reduce health costs and deliver patient benefitbut who should pick up the tab Digital technology is revolutionising healthcare from advanced electronic medical records and telemedicine to....

USD 2495 View Report

Dark Analytics: Shining a Torch for Pharma

By FirstWord Dossier | Healthcare | May 2018 | Page 0

Dark analytics can unlock a wealth of new clinical and commercial insightsbut how can you make it work for you Dark data and dark analytics have the potential to generate huge....

USD 395 View Report

Breast Cancer: KOL Insight [2018]

By FirstWord Dossier | Healthcare | May 2018 | Page 0

KOLs discuss how Roches Perjeta will be used in the future and whether the APHINITY trial results will change prescribing habits. ....

USD 8495 View Report

Nonalcoholic Steatohepatitis (NASH): KOL Insight [2018]

By FirstWord Dossier | Healthcare | May 2018 | Page 0

Are novel therapies set to revolutionise NASH No drug therapies have been approved for patients with nonalcoholic steatohepatitis (NASH) but this could all change in the next 3-5 years. Four late-stage....

USD 8495 View Report